- Home
- IMMP vs BKSY Comparison
IMMP vs BKSY Comparison
Compare IMMP & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- BKSY
- Stock Information
- Founded
- IMMP 1987
- BKSY 2013
- Country
- IMMP Australia
- BKSY United States
- Employees
- IMMP N/A
- BKSY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- IMMP Health Care
- BKSY Technology
- Exchange
- IMMP Nasdaq
- BKSY Nasdaq
- Market Cap
- IMMP 244.5M
- BKSY 157.7M
- IPO Year
- IMMP N/A
- BKSY N/A
- Fundamental
- Price
- IMMP $1.65
- BKSY $25.85
- Analyst Decision
- IMMP Buy
- BKSY Strong Buy
- Analyst Count
- IMMP 1
- BKSY 6
- Target Price
- IMMP $7.00
- BKSY $23.00
- AVG Volume (30 Days)
- IMMP 87.0K
- BKSY 2.4M
- Earning Date
- IMMP 02-27-2025
- BKSY 08-07-2025
- Dividend Yield
- IMMP N/A
- BKSY N/A
- EPS Growth
- IMMP N/A
- BKSY N/A
- EPS
- IMMP N/A
- BKSY N/A
- Revenue
- IMMP $3,019,249.00
- BKSY $107,401,000.00
- Revenue This Year
- IMMP $50.37
- BKSY $31.81
- Revenue Next Year
- IMMP N/A
- BKSY $27.70
- P/E Ratio
- IMMP N/A
- BKSY N/A
- Revenue Growth
- IMMP 24.11
- BKSY 7.05
- 52 Week Low
- IMMP $1.32
- BKSY $3.86
- 52 Week High
- IMMP $2.72
- BKSY $26.27
- Technical
- Relative Strength Index (RSI)
- IMMP 46.73
- BKSY 81.62
- Support Level
- IMMP $1.64
- BKSY $21.10
- Resistance Level
- IMMP $1.74
- BKSY $24.22
- Average True Range (ATR)
- IMMP 0.06
- BKSY 1.92
- MACD
- IMMP 0.01
- BKSY 0.38
- Stochastic Oscillator
- IMMP 66.67
- BKSY 95.73
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.